According to SCYNEXIS's latest financial reports the company's total assets are $0.14 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $87.81 M | -26.73% |
2021-12-31 | $0.11 B | 16.87% |
2020-12-31 | $0.10 B | 79.41% |
2019-12-31 | $57.15 M | 7.49% |
2018-12-31 | $53.17 M | 15.97% |
2017-12-31 | $45.85 M | -23.32% |
2016-12-31 | $59.79 M | 21.35% |
2015-12-31 | $49.27 M | 24.2% |
2014-12-31 | $39.67 M | 220.27% |
2013-12-31 | $12.38 M | 2.22% |
2012-12-31 | $12.11 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Galmed Pharmaceuticals
GLMD | $17.63 M | -88.13% | ๐ฎ๐ฑ Israel |
Catalyst Pharmaceuticals CPRX | $0.47 B | 216.48% | ๐บ๐ธ USA |
Catalent CTLT | $9.98 B | 6,623.84% | ๐บ๐ธ USA |
KemPharm KMPH | $0.11 B | -22.23% | ๐บ๐ธ USA |